Marker related to auxiliary diagnosis of non-small cell lung cancer and application thereof
A non-small cell lung cancer, auxiliary diagnosis technology, applied in the biological field, can solve the problems of unclear role of human tumors, low early diagnosis rate, and no human cancer detection and target therapy.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0046] The present invention uses Real-time PCR and immunohistochemical technology to analyze the expression level of NATD in the tumor specimens and normal tissues of 29 cases of non-small cell lung cancer patients, and finds that the expression level of NATD in the tumor tissues of lung cancer patients is significantly increased, and compared with Patient mortality is positively correlated. A NATDknockdown stable non-small cell lung cancer cell line was constructed, and the migration ability of cancer cells was detected to be impaired. Immunohistochemistry and Real-time PCR detection showed that NATD can regulate the expression of key molecular genes in the process of EMT, and the decrease of NATD expression level can inhibit the process of EMT conversion. NATD without catalytic activity (abbreviated as NATDΔ) was constructed using mutation technology, and in vitro acetylation experiments verified the necessity of the missing acetyl-CoA binding site for the biological activi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com